Login / Signup

Correction to: Is the Availability of Biosimilar Adalimumab Associated with Budget Saving? A Difference-in-Difference Analysis of 14 Countries.

Hyunjung WooGyeongseon ShinDonghwan LeeHye-Young KwonSeung Jin Bae
Published in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2024)
Keyphrases
  • rheumatoid arthritis
  • juvenile idiopathic arthritis
  • ulcerative colitis
  • hidradenitis suppurativa